Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10013412HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013413HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013414HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013415HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013416HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013417HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013418HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013419HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013420HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10019801HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB14185
Drug NameAripiprazole lauroxil
Target IDBE0000045
UniProt IDP20309
Regulation Type
PubMed IDs17848919
CitationsNasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11.
GroupsApproved; Investigational
Direct ClassificationPhenylpiperazines
SMILESCCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Pathways
PharmGKBPA166161216
ChEMBLCHEMBL2219425